In vitro neurotoxicity of magnetic resonance imaging (MRI) contrast agents: Influence of the molecular structure and paramagnetic ion

Toxicology in Vitro

Volumn 24, Issue 5, 2010, Pages 1386-1394

  Bertin, Annabelle ^a   Michou Gallani, Anne Isabelle ^b   Gallani, Jean Louis ^a   Felder Flesch, Delphine ^a  

^a INSTITUT DE PHYSIQUE ET CHIMIE DES MATÉRIAUX DE STRASBOURG   (France)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Dendrimers; GdDTPA; MnDPDP; MRI contrast agents; Neurotoxicity; Rat cerebellar neurons

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE; LACTATE DEHYDROGENASE; MANGAFODIPIR; MANGANESE; MANGANESE DIOXIDE; PENTETIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL STRUCTURE; CELL VIABILITY; CEREBELLUM; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; ENZYME ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOLECULAR WEIGHT; NERVE CELL CULTURE; NEURITE; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SOLUBILITY; TOXICOLOGICAL PARAMETERS;

ANIMALS; CELLS, CULTURED; CONTRAST MEDIA; EDETIC ACID; GADOLINIUM DTPA; LACTATE DEHYDROGENASES; MAGNETIC RESONANCE IMAGING; NEURONS; PYRIDOXAL PHOSPHATE; RATS;

RATTUS;

EID: 77953615761     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.05.001     Document Type: Article

References (49)

1. Adding L.C., et al. Basic experimental studies and clinical aspects of gadolinium salts and chelates. Cardiovasc. Drugs Rev. 2001, 19:41-56.
2. Albrecht J., Matyja E. Glutamate: a potential mediator of inorganic mercury neurotoxicity. Metabolic Brain Disease 1996, 11:175-184.
3. Ali S.F., et al. Manganese-induced reactive oxygen species: comparison between Mn{thorn}2 and Mn{thorn}3. Neurodegeneration 1995, 4:329-334.
4. Archibald F.S., Tyree C. Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch. Biochem. Biophys. 1987, 256:638-650.
5. Benedetto A., et al. Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease. Chem. Rev. 2009, 109:4862-4884.
6. Bertin A., et al. Development of a dendritic manganese-enhanced magnetic resonance imaging (MEMRI) contrast agent: synthesis, toxicity (in vitro) and relaxivity (in vitro, in vivo) studies. Bioconj. Chem. 2009, 20:760-767.
7. Betteridge D.J. What is oxidative stress?. Metabolism 2000, 49:3-8.
8. Brouillet E.P., et al. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp. Neurol. 1993, 120:89-94.
9. Bruecher E., Sherry A.D. Stability and toxicity of contrast agents 2001, John Wiley and Sons Ltd., Chichester.
10. Cheng Y.-C., et al. B chain is a functional subunit of .beta.-bungarotoxin for inducing apoptotic death of human neuroblastoma SK-N-SH cells. Toxicon 2008, 51:304-315.
11. Crossgrove J., Zheng W. Manganese toxicity upon overexposure. NMR Biomed. 2004, 17:544-553.
12. De Meo M., et al. Genotoxic activity of potassium permanganate in acidic solutions. Mutat. Res. 1991, 260:295-306.
13. Dobson A.W., et al. Manganese neurotoxicity. Ann. NY Acad. Sci. 2004, 1012:115-128.
14. Dukhande V.V., et al. Manganese-induced neurotoxicity is differentially enhanced by glutathione depletion in astrocytoma and neuroblastoma cells. Neurochem. Res. 2006, 31:1349-1357.
15. Duncan R., Izzo L. Dendrimer biocompatibility and toxicity. Adv. Drug Deliv. Rev. 2005, 57:2215-2237.
16. Edward M., et al. Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis. J. Pathol. 2008, 214:584-593.
17. Fitsanakis V.A., Aschner M. The importance of glutamate, glycine, and .gamma.-aminobutyric acid transport and regulation in manganese, mercury and lead neurotoxicity. Toxicol. Appl. Pharmacol. 2005, 204:343-354.
18. Fu L.J., et al. Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH 3T3 cells. J. Biol. Inorg. Chem. 2009, 14:219-227.
19. Gallez B., et al. Accumulation of manganese in the brain of mice after intravenous injection of manganese-based contrast agents. Chem. Res. Toxicol. 1997, 10:360-363.
20. Gavin C.E., et al. Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. Biochem. J. 1990, 266:329-334.
21. Gilani S.H., Alibhai Y. Teratogenicity of metals to chick embryo. J. Toxicol. Environ. Health 1990, 30:23-31.
22. Idee J.-M., et al. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review. Toxicology 2008, 248:77-88.
23. 2+ - adenosine triphosphatase of sarcoplasmic reticulum. J. Biochem. 1984, 95:661-669.
24. Joardar M., Sharma A. Comparison of clastogenicity of inorganic Mn administered in cationic and anionic forms in vivo. Mutat. Res. 1990, 240:159-163.
25. Kroemer G., et al. The biochemistry of programmed cell death. FASEB J. 1995, 9:1277-1287.
26. Kwik-Uribe C.L., et al. Alterations in cellular IRP-dependent iron regulation by in vitro manganese exposure in undifferentiated PC12 cells. Brain Res. Brain Res. Rev. 2003, 973:1-15.
27. Lauffer R.B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. 1987, 87:901-927.
28. Levy B.S., Nassetta W.J. Neurologic effects of manganese in humans: a review. Int. J. Occup. Environ. Health 2003, 9:153-163.
29. Malik N., et al. Dendrimers: relationship between structure and biocompatibility in vitro and preliminary studies on the biodistribution of I-labelled polyamidoamine dendrimers in vivo. J. Controll. Release 2000, 65:133-148.
30. Milatovic D., et al. Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol. Sci. 2007, 98:198-205.
31. Misselwitz B., et al. A toxicologic risk for using manganese complexes? A literature survey of existing data through several medical specialties. Invest. Radiol. 1995, 30:611-620.
32. Normandin L., et al. Manganese neurotoxicity: behavioral, pathological, and biochemical effects following various routes of exposure. Rev. Environ. Health 2002, 17:189-217.
33. Okazaki M., et al. Assessment of potential neurotoxic actions of organoarsenic compounds using human neuroblastoma NB-1 cells and rat cerebellar neurons in primary culture. J. Health Sci. 2003, 49:410-415.
34. Olanow C.W. Manganese-induced Parkinsonism and Parkinson's disease. Ann. NY Acad. Sci. 2004, 1012:209-223.
35. Orrenius S., et al. Mitochondrial oxidative stress: implications for cell death. Ann. Rev. Pharmacol. Toxicol. 2007, 47:143-183.
36. Palasz A., Czekaj P. Toxicological and cytophysiological aspects of lanthanides action. Acta Biochim. Polonica 2000, 47:1107-1114.
37. Port M., et al. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. BioMetals 2008, 21:469-490.
38. Prohaska J.R. Functions of trace elements in brain metabolism. Physiol. Rev. 1987, 67:858-901.
39. Sarkander H.I., Brade W.P. On the mechanism of lanthanide-induced liver toxicity. Arch. Toxicol. 1976, 36:1-17.
40. Silva R.F.M., et al. Dissociated primary nerve cell cultures as models for assessment of neurotoxicity. Toxicol. Lett. 2006, 163:1-9.
41. Silva R.F.M., et al. Rat cultured neuronal and glial cells respond differently to toxicity of unconjugated bilirubin. Pediat. Res. 2002, 51:535-541.
42. Tahti H., et al. In vitro methods as a tool in neurotoxicity studies. Altern. Lab. Anim. 1995, 23:491-496.
43. Treinen K.A., et al. Developmental toxicity of mangafodipir trisodium and manganese chloride in sprague-dawley rats. Teratology 1995, 52:109-115.
44. Varani J., et al. Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts. Invest Radiol. 2009, 44:74-81.
45. Wedeking P., et al. Dissociation of gadolinium chelates in mice relationship to chemical characteristics. Mag. Reson. Imag. 1992, 10:641-648.
46. Wyllie A.H., et al. Cell death: the significance of apoptosis. Int. Rev. Cytol. 1980, 68:251-306.
47. Yamada M., et al. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol. 1986, 70:273-278.
48. Zhang Y., et al. Gadolinium promoted proliferation and enhanced survival in human cervical carcinoma cells. Biometals 2009, 22:511-519.
49. Zheng W., Zhao Q. Iron overload following manganese exposure in cultured neuronal, but not neuroglial cells. Brain Res. Brain Res. Rev. 2001, 897:175-179.